Davidson Investment Advisors Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Davidson Investment Advisors bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 18,857 shares of the healthcare conglomerate’s stock, valued at approximately $9,539,000.

A number of other large investors also recently bought and sold shares of the stock. Kentucky Retirement Systems Insurance Trust Fund raised its position in shares of UnitedHealth Group by 30.4% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 35,652 shares of the healthcare conglomerate’s stock worth $18,035,000 after acquiring an additional 8,312 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its position in UnitedHealth Group by 67.7% during the fourth quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 3,969 shares of the healthcare conglomerate’s stock worth $2,009,000 after purchasing an additional 1,602 shares in the last quarter. Valley Wealth Managers Inc. increased its position in shares of UnitedHealth Group by 6.7% in the fourth quarter. Valley Wealth Managers Inc. now owns 1,145 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 72 shares in the last quarter. Key Financial Inc lifted its position in shares of UnitedHealth Group by 2.2% during the 4th quarter. Key Financial Inc now owns 3,892 shares of the healthcare conglomerate’s stock valued at $1,969,000 after buying an additional 84 shares in the last quarter. Finally, Waycross Partners LLC increased its holdings in UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock worth $14,060,000 after acquiring an additional 658 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently commented on UNH shares. Barclays cut their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Truist Financial reduced their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $523.48 on Tuesday. The firm has a market cap of $481.75 billion, a P/E ratio of 33.77, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm’s 50 day moving average price is $523.11 and its 200-day moving average price is $563.00.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.